CD28 and clear cell renal carcinoma: Taken together, our results suggest that low CpG 4/5 methylation is associated with aggressiveness but higher response to ICB which is in-line with our previous findings regarding methylation of the second member of the CD28 immune receptor family and co-localized gene CTLA4 in melanoma and clear cell renal cell carcinoma [21–23].